Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model

Yihai Liu,1,2,* Mingyue Wu,1,* Biao Xu,1 Lina Kang1 1Department of Cardiology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, Jiangsu, People’s Republic of China; 2Department of Cardiology, Affiliated Drum Tower Hospital, Clinical College of Nanjing Medica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liu Y, Wu M, Xu B, Kang L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/ba026a2cfd9b44928fce8329a5e600ac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!